Positron Emission Tomography (PET)
Mount Sinai Nuclear Medicine Associates offers the full range of PET studies utilizing a state-of-the-art Advance GE PET scanner. Positron Emission Tomography is a sophisticated molecular functional imaging technique, using advanced technology to display the functional status of tissues in the body at the cellular level.
PET scanning can detect changes in cell function or disease well before they become evident on CT or MRI, and can provide diagnostic information simply not available from anatomic imaging modalities like CT or MR. PET is particularly useful in the evaluation of a solitary lung nodule, lung cancer, colon cancer, melanoma, esophageal cancer, lymphoma, head and neck cancer, and staging of breast cancer.
PET is indicated for the evaluation of refractory seizures and evaluation of cardiac perfusion and myocardial viability. PET is also useful in the evaluation of dementia and Alzheimer's disease.